Array Biopharms To Restructure | Chemical & Engineering News
Volume 89 Issue 25 | p. 22 | Concentrates
Issue Date: June 20, 2011

Array Biopharms To Restructure

Department: Business
Keywords: R&D, pharmaceuticals

Array BioPharma is restructuring to reduce its spending rate and focus on its key clinical development programs, which are largely in the cancer area. The firm will reduce its workforce by about 20%, or 70 employees, primarily in discovery research and support jobs. It will still have a small discovery research group to handle late-stage projects and its partnerships with Amgen, Celgene, and Genentech.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment